Donnie Yance is an internationally known master herbalist and nutritionist. He is the author of the book, "Herbal Medicine, Healing and Cancer" and "Adaptogens in Medical Herbalism"
False information can spread like wildfire, particularly during times of fear and uncertainty. Right now, there is misinformation circulating about elderberry (Sambucus nigra) and COVID-19.
Elderberry extract is being falsely accused of triggering a cytokine storm or cytokine release syndrome (CRS), an intense inflammatory response that can be deadly. During the SARS epidemic, CRS caused severe lung damage and was a driving factor in many fatalities.
“I go into my library and all history unrolls before me.” Alexander Smith
In Western tradition, boneset is perhaps the single most important herb for combating the flu. There have been six major influenza pandemics (worldwide outbreaks) since 1889. The 1918 influenza pandemic (“Spanish flu”) was the deadliest pandemic in history. Approximately 5% of the world’s population was infected, and the number of deaths has been estimated at 50 million (CDC).
Boneset (Eupatorium perfoliatum) might be the single best herbal remedy for influenza. During the severe “Spanish Flu” pandemic, boneset was one of the safest and most successful remedies employed and contributed much to the successful management of the disease under the Eclectic treatment.
Continue reading “Boneset (Eupatorium Perfoliatum) Monograph”
The last time I wrote a blog post on vaccines and vaccinating, it generated quite a bit of conversation and raised some very good questions. It is hard to find the “truth” about vaccines, if you want to hear the entire truth. One thing is certain: It would be a lot more fruitful if people on both sides of the debate stopped exaggerating the facts to make their point.
Continue reading “The Trend Toward Over-Vaccinating and the Need for Long-Term Research”
A great deal of fear surrounds the combination of botanical medicine and modern medicine that isn’t based in truth or scientific rigor, but rather on theory or hearsay. Unfortunately, that deters many patients from treatment protocols that can greatly enhance their quality of life and prolong their life as well.
There is an extensive body of research demonstrating in vitro and in vivo (animal and human) synergy between natural products and anti-cancer drugs including chemotherapy, targeted agents, and immunotherapy against primary cancer, cancer resistance, and particularly cancer stem cells.
Continue reading “Botanical Compounds in Cancer Combination Therapies”
I often find myself thinking that modern medicine has it all wrong when it comes to treating cancer. Miraculous new treatments for cancer make headlines every day, but what are the long-term results of these treatments? Are these wonder drugs truly extending life, and more importantly, are they enhancing quality of life?
According to a recently published paper in the British Medical Journal, one of the most prestigious, peer-reviewed medical journals, more than one-half of cancer drugs approved by the European Medicines Agency from 2009 to 2013 show no improvement in quality of life or survival.
Continue reading “Are “Wonder Drugs” the Answer to Curing Cancer?”
Understanding Neutrophil to Lymphocyte Ratio (Part 2): Research Demonstrating its Role as a Valuable Prognostic Marker in Cancer
A large body of research (as well as my clinical observations) point to chronic inflammation as a powerful force in the initiation, growth, and spread of cancer. As a result, an essential component of my protocol for health includes addressing inflammation.
As I discussed in part 1 of this series, there are three points to consider when evaluating the role of inflammation in cancer. First, a chronic inflammatory state can initiate cancer development. Second, it’s important to discover and address the root cause of the inflammation—for example, pathogenic (chronic infection), life-style, stress, and/or poor dietary habits. And third, recognize that the cancer itself creates inflammation—as the cancer energy mutates and gains intelligence, it manipulates the immune system, creating a pro-inflammatory micro-environment favorable to cancer growth.
Research indicates that the systemic manifestations of inflammation can provide a valuable biomarker for prognosis and treatment stratification. In particular, numerous studies indicate that a simple indicator of systemic inflammation—based on neutrophilia and/or lymphocytopenia—can provide prognostic information in a wide range of cancer types. In particular, the value of one index (the dNLR) derived from total white cell and neutrophil counts, is enabling large retrospective studies to be carried out.
Neutrophil to Lymphocyte Ratio May Be a Predictor of Mortality in All Conditions
White blood cell (WBC) count is one of the useful inflammatory biomarkers in clinical practice. For example, even if WBC is within normal range, subtypes of WBC including N/L ratio may predict cardiovascular mortality.
N/L ratio is a readily measurable laboratory marker used to evaluate systemic inflammation. There are many different conditions that can affect N/L ratio, including hypertension, diabetes mellitus, metabolic syndrome (1), left ventricular dysfunction, acute coronary syndromes, valvular heart disease, abnormal thyroid function tests, renal or hepatic dysfunction, known malignancy (2,3,4), local or systemic infection, previous history of infection (<3 months), inflammatory diseases, and any medication related to inflammatory conditions.
Here’s one example of how the N/L ratio can be useful as part of the evaluation of a specific cancer and the treatment protocol: not only N/L ratio but also mean platelet volume, red cell distribution width (5), platelet distribution width, CRP, uric acid and gamma-glutamyl transferase (6) are easy markers to evaluate the prognosis of colon cancer patients (7). However, one should keep in mind that N/L ratio itself alone without other inflammatory markers may not give exact information to clinicians about the prognosis of colon cancer patients. (8,9).